Company intelligence / Profile preview

Oxford Capital

Oxford, England, United Kingdom

Ownership: Private
Employees: ~18
Development stage: Other

Overview

Oxford Capital is a UK-based venture capital investment firm, founded in 1999, investing in early-stage to growth-stage UK technology and science companies across sectors including (but not limited to) biotech and healthcare; it is not itself a developer of drugs or medical technology

Industry: Investors

Partnerships

Mercuri (investment partner)Shilling (investment partner)Seraphim Capital (investment partner)MTI (investment partner)

Beyond the preview

Go deeper on Oxford Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxford Capital.

Explore the full profile